17 May 2023
RNZ's Kathryn Ryan talks to our Clinical Director Dr Rob Weinkove about our CAR T-cell clinical trial, what a recent commercial deal with global pharmaceutical Dr. Reddy's means and his ambition to see this become a mainstream treatment.
Related articles
New Zealand to New York and back again: Malaghan researcher tackling liver cancer
18 November 2024
Read more
Community partnerships: Zephyr Consulting empowering emerging scientific talent
18 November 2024
Read more
In Focus: CAR T-cell therapy, the battle of the blood cells
26 September 2024
Read more
In Focus: CAR T-cell therapy, the battle of the blood cells
26 September 2024
Read more
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
Read more
Phase 2 clinical trial underway to confirm effectiveness and safety of NZ’s first CAR T-cell cancer therapy
23 July 2024
Read more